Inspire Medical price target raised to $260 from $255 at Piper Sandler
The Fly

Inspire Medical price target raised to $260 from $255 at Piper Sandler

Piper Sandler raised the firm’s price target on Inspire Medical (INSP) to $260 from $255 and keeps an Overweight rating on the shares. The firm notes the company reported strong Q3 results with the top-line coming in comfortably above the Street, while EPS of 60c was well above its model and consensus. Inspire also increased its FY2024 top-line guidance to $793M-$798M, representing a $2.5M increase from previous range at-the-midpoint, which reflects some transient headwinds from hurricanes/IV solutions shortage, Piper adds.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App